Never miss a Delaware County story!
Idorsia Therapeutics is negotiating to sell global rights to its high blood pressure drug amid a restructuring that could eliminate up to 270 positions, writes…
Swiss biopharmaceutical company Idorsia Ltd. has entered into negotiations to operate in the Asia Pacific region and gain licensing rights there for its products, writes…
Before we send you to this site, please subscribe to our daily newsletter.
